Clinical trial

Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine…

NCT00183911 · University of Southern California, Other · Completed

Key facts

NCT number NCT00183911
Title Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma
Official title Phase II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-Fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma
Lead sponsor University of Southern California, Other
Collaborators National Cancer Institute (NCI) NIH New York University
Status Completed
Phase Phase 2
Study type Interventional
Conditions Gastric Adenocarcinoma, Gastric Cancer
Intervention type Drug, Procedure
Interventions floxuridine, 5-Fluorouracil, leucovorin, External Beam Radiotherapy, Surgery
Enrollment 25
Start date Nov 1, 2003
Primary completion Dec 1, 2006
Completion Apr 1, 2007
First posted Sep 16, 2005
Last update posted May 22, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies